Company Filing History:
Years Active: 2014-2017
Title: Jeff Krieger: Innovator in Vaccine Development
Introduction
Jeff Krieger is a notable inventor based in Newtonville, MA (US). He has made significant contributions to the field of vaccine development, holding 2 patents that focus on innovative methods for designing and preparing vaccines.
Latest Patents
Krieger's latest patents include "Methods for designing and preparing vaccines comprising directed sequence polymer compositions via the directed expansion of epitopes." This invention outlines a process for preparing a composition that utilizes directed sequence polymer (DSP) mixtures as epitopes, which are useful in vaccine development. The DSP is synthesized based on specific rules regarding the identity and frequency of amino acids that replace a base or native amino acid of a known epitope. The resulting composition consists of a mixture of related peptides intended for therapeutic use as a vaccine, particularly against immune evasive infectious agents.
Another significant patent is "Serum protein-based detection of random sequence polymer compositions." This application addresses the challenges in detecting simple peptides and provides improved methods for assessing random sequence polymer (RSP) compositions. It includes techniques for detecting and quantifying RSP compositions, as well as methods for administering these compositions to subjects in need, with dosage regimens based on the detection methods.
Career Highlights
Throughout his career, Jeff Krieger has worked with various companies, including Declion Holdings LLC and Ares Trading S.a. His work has focused on advancing the science of vaccine development and peptide detection.
Collaborations
Krieger has collaborated with notable individuals in his field, including Eric Zanelli and Dustan Bonnin. These collaborations have contributed to the advancement of his innovative work.
Conclusion
Jeff Krieger is a prominent inventor whose work in vaccine development and peptide detection has the potential to significantly impact public health. His innovative patents reflect his commitment to advancing scientific knowledge and improving therapeutic options.